Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers
Nasser A. Dhayat(University of Bern), Daniel G. Fuster(University of Bern), Orson W. Moe(Io Therapeutics (United States)), Lisa Schneider(University Hospital of Bern), Bruno Vogt(Hypertension Institute), Michael W. Gradwell(University Hospital of Bern), Ganesh Pathare(University of Bern), Cédric Mattmann(University Hospital of Bern), Manuel Anderegg(University of Bern), David Luethi(University Hospital of Bern)
Cited by 52
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis
|Kidney International|2002|346